Ticker Scorecard - DTIL Basics Company: Precision BioSciences, Inc. IPO Date: May 25, 2019 Sector: Healthcare Industry: Biotech Market Cap: $34.52M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 3.77% Avg Daily Range (30 D): $0.30 | 5.71% Avg Daily Range (90 D): $0.22 | 3.36% Institutional Daily Volume Avg Daily Volume: .04M Avg Daily Volume (30 D): .63M Avg Daily Volume (90 D): .26M Trade Size Avg Trade Size (Sh.): 11 Avg Trade Size (Sh.) (30 D): 134 Avg Trade Size (Sh.) (90 D): 135 Institutional Trades Total Inst.Trades: 317 Avg Inst. Trade: $1.41M Avg Inst. Trade (30 D): $.62M Avg Inst. Trade (90 D): $.62M Avg Inst. Trade Volume: .01M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.55M Avg Closing Trade (30 D): $1.21M Avg Closing Trade (90 D): $1.21M Avg Closing Volume: 6.87K     News Sep 10, 2024 @ 9:00 AM Global Genetic Engineering Market Size To Worth US... Source: Spherical Insights & Consulting Sep 10, 2024 @ 8:51 AM Gene Editing Therapeutics Market Forecast 2024-202... Source: Researchandmarkets.Com May 29, 2024 @ 1:55 PM Does Precision BioSciences (DTIL) Have the Potenti... Source: Zacks Equity Research May 16, 2024 @ 6:00 PM Deep Dive Into Precision BioSciences Stock: Analys... Source: Benzinga Insights May 9, 2024 @ 9:45 PM Kronos Bio, Inc. (KRON) Reports Q1 Loss, Tops Reve... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.19 $-2.25 $4.7 Diluted EPS $-.28 $-2.25 $4.67 Revenue $ 75.1M $ .58M $ 49.9M Gross Profit $ $ $ Net Income / Loss $ 8.62M $ -16.43M $ 32.75M Operating Income / Loss $ -16.21M $ -21.28M $ 24.15M Cost of Revenue $ $ $ Net Cash Flow $ -.9M $ -2.24M $ -14.2M PE Ratio     Splits Feb 14, 2024:   30:1